# P. Fumoleau

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/p-fumoleau/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,627 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 72 |
| i10-index | 220 |
| Last Known Institution | Institut Curie |
| OpenAlex ID | https://openalex.org/A5012804079 |
| ORCID iD | https://orcid.org/0000-0002-2912-2170 |
| Works | 491 |

## Researcher papers

- [Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.](https://scholariq.org/papers/polychemotherapy-for-early-breast-cancer-an-overview-of-the-randomised-trials/)
- [Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer](https://scholariq.org/papers/randomized-phase-iii-placebo-controlled-trial-of-letrozole-plus-oral/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [Institut Curie](https://scholariq.org/institutions/institut-curie/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.